Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: McCormick & Company Incorporated, 3 years.
McCormick & Company Incorporated
Director
Nuvation Bio Inc.
Director
NovoCure Limited
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | NovoCure Limited | Grant or award | +11,610 | — | — |
| Jun 2, 2026 | NovoCure Limited | Open-market sale | −2,945 | $15.77 | $46,443 |
| Apr 28, 2026 | NovoCure Limited | Option exercise | +21,500 | $11.39 | $244,885 |
| Feb 15, 2026 | McCormick & Company Incorporated | Option exercise | +2,222 | — | — |
| Jun 4, 2025 | NovoCure Limited | Grant or award | +11,215 | — | — |
| Jun 3, 2025 | NovoCure Limited | Open-market sale | −999 | $17.35 | $17,333 |
| Mar 15, 2025 | McCormick & Company Incorporated | Option exercise | +1,344 | — | — |
| Jun 5, 2024 | NovoCure Limited | Grant or award | +4,053 | — | — |
| Jun 4, 2024 | NovoCure Limited | Open-market sale | −964 | $23.89 | $23,030 |
| Mar 15, 2024 | McCormick & Company Incorporated | Option exercise | +1,255 | — | — |
| Jun 7, 2023 | NovoCure Limited | Grant or award | +3,853 | — | — |
| Mar 15, 2023 | McCormick & Company Incorporated | Option exercise | +1,044 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.